In the past decade, extracellular vesicles (EVs) have emerged as a key cell-free strategy for
the treatment of a range of pathologies, including cancer, myocardial infarction, and …

Within the past decade, extracellular vesicles have emerged as important mediators of
intercellular communication, being involved in the transmission of biological signals …

Mesenchymal stem cell (MSC)-derived exosomes have been recognized as new candidates
for cell-free treatment of various diseases. However, maintaining the retention and stability of …

Extracellular vesicles (EVs) derived from mesenchymal stem cells (MSC-EVs) have been
recognized as a promising cell-free therapy for acute kidney injury (AKI), which avoids safety …

Extracellular vesicles (EVs) are specialised endogenous carriers of proteins and nucleic
acids and are involved in intercellular communication. EVs are therefore proposed as …

Using oligonucleotide-based drugs to modulate gene expression has opened a new avenue
for drug discovery. In particular small interfering RNAs (siRNAs) are being rapidly …

Extracellular vesicles (EVs) are a heterogeneous population of secreted membrane
vesicles, with distinct biogenesis routes, biophysical properties and different functions both …

Compelling evidence exists that non-haematopoietic stem cells, including mesenchymal
(MSCs) and neural/progenitor stem cells (NPCs), exert a substantial beneficial and …

Stem cell-based therapies for neurodegenerative diseases aim at halting clinical
deterioration by regeneration and by providing local support for damaged tissue …

Mesenchymal stem cells (MSCs) are adult stem cells owing to their regenerative potential
and multilineage potency. MSCs have wide-scale applications either in their native cellular …